ZNF503 inhibits GATA3 expression, a key regulator of mammary LEP differentiation, and its downregulation is associated with aggressive breast cancers (Kouros-Mehr et al., 2006; Shahi et al., 2017). Here, GATA3 is linked to breast carcinoma.